Overview |
bsm-90245R |
CD82 Recombinant Antbody Kit (KD-Validated) |
WB, FCM, IC |
Knockdown Validated |
Human |
Specifications |
Unconjugated |
Rabbit |
A synthesized peptide derived from human CD82 |
200-267/267 |
Monoclonal |
IgG |
Lot dependent |
Affinity Purified |
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
-20 °C |
Target |
3732 |
P27701 |
CD82; CD82 Molecule 2; TSPAN27; IA4; CD82 Antigen; KAI1; R2; Kangai 1 (Suppression Of Tumorigenicity 6 Prostate; CD82 Antigen (R2 Leukocyte Antigen Antigen Detected By Monoclonal And Antibody IA4)); Metastasis Suppressor Kangai-1; Inducible Membrane Protein R2; Tetraspanin-27; C33 Antigen; Tspan-27; SAR2; Suppressor Of Tumorigenicity 6 Protein; Suppression Of Tumorigenicity 6; R2 Leukocyte Antigen; GR15; 4F9; C33 |
Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
Application Dilution |
WB |
1:300-5000 |
FCM |
1:20-100 |
IC |
1:1000 |